• Bio Essence appointed Xiying (Thea) Zhang and Geoff Fellows as independent directors, effective October 19, 2026.
• The appointments expanded the board from three to five members, making it majority independent.
• Zhang, formerly a senior supply chain leader with Oasis Pharmaceutical, brings more than 15 years of medical device and pharmaceutical experience.
• Fellows, CEO of Embarcadero Accessible Multi-Family Office and formerly its operations and compliance chief, brings more than three decades of financial-sector experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Essence Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610260800ACCESSWRNAPR_____1241282) on October 26, 2026, and is solely responsible for the information contained therein.